Hedge Fund - RA Capital Management
Rhythm Pharmaceuticals Inc. (RYTM)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $245,039,040 | 3.82% | 5,330,412 | $31.55 |
| 2 | 2023 - Q3 (2023-09-30) | $130,123,836 | 2.56% | 5,676,067 | $22.39 |
| 3 | 2023 - Q2 (2023-06-30) | $93,598,345 | 1.76% | 5,676,067 | $18.05 |
| 4 | 2023 - Q1 (2023-03-31) | $98,406,635 | 2.22% | 5,516,067 | $25.11 |
| 5 | 2022 - Q4 (2022-12-31) | $160,627,871 | 3.25% | 5,516,067 | $25.70 |
| 6 | 2022 - Q3 (2022-09-30) | $134,041,000 | 2.85% | 5,471,067 | $18.60 |
| 7 | 2022 - Q2 (2022-06-30) | $20,215,000 | 0.53% | 4,871,067 | $5.47 |
| 8 | 2022 - Q1 (2022-03-31) | $56,115,000 | 1.22% | 4,871,067 | $8.78 |
| 9 | 2021 - Q4 (2021-12-31) | $48,613,000 | 0.85% | 4,871,067 | $11.23 |
| 10 | 2021 - Q3 (2021-09-30) | $63,616,000 | 0.88% | 4,871,067 | $15.27 |
| 11 | 2021 - Q2 (2021-06-30) | $71,077,000 | 1.14% | 4,871,067 | $20.76 |
| 12 | 2021 - Q1 (2021-03-31) | $103,608,000 | 1.56% | 4,871,067 | $29.00 |
| 13 | 2020 - Q4 (2020-12-31) | $124,244,000 | 1.73% | 4,179,067 | $25.42 |
| 14 | 2020 - Q3 (2020-09-30) | $111,393,000 | 2.03% | 5,140,408 | $22.93 |
| 15 | 2020 - Q2 (2020-06-30) | $116,185,000 | 2.26% | 5,210,088 | $19.49 |
| 16 | 2020 - Q1 (2020-03-31) | $82,528,000 | 2.6% | 5,422,312 | $17.90 |
| 17 | 2019 - Q4 (2019-12-31) | $124,496,000 | 3.77% | 5,422,312 | $22.21 |
| 18 | 2019 - Q3 (2019-09-30) | $73,888,000 | 4.4% | 3,422,312 | $21.45 |
| 19 | 2019 - Q2 (2019-06-30) | $41,465,000 | 2.22% | 1,884,782 | $25.25 |
| 20 | 2019 - Q1 (2019-03-31) | $51,662,000 | 2.22% | 1,884,782 | $28.74 |
| 21 | 2018 - Q4 (2018-12-31) | $52,425,000 | 3.05% | 1,950,332 | $27.64 |
| 22 | 2018 - Q3 (2018-09-30) | $56,891,000 | 3.04% | 1,950,332 | $31.60 |
| 23 | 2018 - Q2 (2018-06-30) | $48,195,000 | 3.12% | 1,541,743 | $27.34 |
The displayed share prices are average quarterly stock market prices.